Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.
Rogado J, Romero-Laorden N, Sanchez-Torres JM, Ramos-Levi AM, Pacheco-Barcia V, Ballesteros AI, Arranz R, Lorenzo A, Gullon P, Garrido A, Serra López-Matencio JM, Donnay O, Adrados M, Costas P, Aspa J, Alfranca A, Mondejar R, Colomer R.
Rogado J, et al. Among authors: donnay o.
Oncoimmunology. 2020 Apr 16;9(1):1751548. doi: 10.1080/2162402X.2020.1751548. eCollection 2020.
Oncoimmunology. 2020.
PMID: 32363123
Free PMC article.